Current liabilities increased 43.7%
Current liabilities changed +43.7% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Current liabilities changed +43.7% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Revenue changed +37.7% from the comparable as-filed period.
Inventory changed +48.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating margin changed +1012 basis points from the comparable as-filed period.
Research & development changed +55.8% from the comparable as-filed period.
Operating income changed +31.3% from the comparable as-filed period.
Operating cash flow changed +45.8% from the comparable as-filed period.
Capex / revenue changed +369 basis points from the comparable as-filed period.
Current assets changed +15.9% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Net income changed +33.7% from the comparable as-filed period.
SBC / revenue changed -338 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.